William is a PhD-qualified biomedical scientist with over 18 years of experience providing scientific, technical, and business leadership in biopharmaceutical drug development. William has expert knowledge of immuno-oncology, the drug development process (particularly clinical and CMC), and “Good Practice” quality systems and recently obtained a distinction in an executive MBA from the University of Oxford, Saïd Business School, gaining a variety of highly transferable business and leadership skills. In his current role, William is working with Autolus Ltd leading the Patient and Cell Management team.